NCT03593031View on ClinicalTrials.gov

Neural Mechanism of Vision Therapy for Patients With Convergence Insufficiency

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 1, 2014

Primary Completion Date

April 1, 2019

Study Completion Date

January 1, 2020

Conditions
Convergence Insufficiency
Interventions
BEHAVIORAL

Office Based Vergence and Accommodative Therapy

Exercises that will stimulate disparity vergence or accommodation independently and then combined will be used.

Trial Locations (1)

07102

NJIT, Newark

All Listed Sponsors
collaborator

National Eye Institute (NEI)

NIH

lead

New Jersey Institute of Technology

OTHER

NCT03593031 - Neural Mechanism of Vision Therapy for Patients With Convergence Insufficiency | Biotech Hunter | Biotech Hunter